InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Hirmand Mohammad, Vice-Président Exécutif. Insider active across 1 companies, notably Turning Point Therapeutics, Inc.. Aggregated, 2 filings have been published. Total volume traded: €43k. The latest transaction was filed on 9 February 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€21,263669 shares@ €31.7828100.0% of flow
Common Stock
SEC:0001209191-22-008980·
€21,263669 shares@ €31.782850.0% of flow
Common Stock
SEC:0001209191-22-008980:0·
2 of 2 declarations
About Hirmand Mohammad
Mohammad Hirmand is the Executive Vice President and Chief Medical Officer at Turning Point Therapeutics, Inc. He is responsible for the medical direction of the company, overseeing the development and implementation of clinical strategies. Hirmand plays a crucial role in therapeutic innovation, aiming to improve treatments for patients. His expertise in medicine and clinical research is a major asset for Turning Point.
